TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36087303

Group type: EXPERIMENTAL
Intervention: DaxibotulinumtoxinA 40 U
Number of subjects: 2785
Study: 33983512

Group type: EXPERIMENTAL
Intervention: 40 mg HBB intravenously
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (2 ml)
Number of subjects: 100
Study: 32957406

Group type: EXPERIMENTAL
Intervention: Psychological nursing intervention along with routine care
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 90
Study: 35889746

Group type: EXPERIMENTAL
Intervention: Low-dose quadruple therapy with bismuth (two capsules of Pylera® plus 250 mg each of tetracycline and metronidazole)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Low-dose quadruple therapy with Lactobacillus reuteri (Gastrus®), one tablet twice-a-day for 27 days
Number of subjects: 46

Group type: COMPARATOR
Intervention: Both groups (bismuth and Lactobacillus reuteri)
Number of subjects: 46
Study: 32253042

Group type: EXPERIMENTAL
Intervention: 2% HCSP
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 4% HCSP
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 6% HCSP
Number of subjects: 48

Group type: COMPARATOR
Intervention: 0% HCSP
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Overall HCSP increase
Number of subjects: 48
Study: 36971803

Group type: EXPERIMENTAL
Intervention: Process-responsible nursing (PP)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 400
Study: 33159999

Group type: EXPERIMENTAL
Intervention: Neuraminidase inhibitors (NAIs) for influenza B treatment; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polymerase inhibitor baloxavir in high-risk influenza B patients; specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 32164439

Group type: EXPERIMENTAL
Intervention: Lung cancer screening (LCS) by low-dose computed tomography (LDCT)
Number of subjects: 986

Group type: COMPARATOR
Intervention: Known COPD
Number of subjects: 986

Group type: COMPARATOR
Intervention: Undiagnosed COPD
Number of subjects: 986

Group type: EXPERIMENTAL
Intervention: Spirometry findings added to LDCT
Number of subjects: 986

Group type: EXPERIMENTAL
Intervention: Airflow obstruction (GOLD 1 and 2)
Number of subjects: 986

Group type: EXPERIMENTAL
Intervention: Airflow obstruction (GOLD 3 and 4)
Number of subjects: 986

Group type: EXPERIMENTAL
Intervention: Emphysema (mild)
Number of subjects: 986

Group type: EXPERIMENTAL
Intervention: Emphysema (moderate)
Number of subjects: 986

Group type: EXPERIMENTAL
Intervention: Emphysema (severe)
Number of subjects: 986
Study: 35799647

Group type: EXPERIMENTAL
Intervention: Modified wristband
Number of subjects: 260

Group type: COMPARATOR
Intervention: Traditional wristband
Number of subjects: 260
Study: 34446666

Group type: EXPERIMENTAL
Intervention: Increased resident agitation
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: For-profit ownership
Number of subjects: 379
Study: 34288117

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 0
Study: 33932482

Group type: EXPERIMENTAL
Intervention: Real-time functional near infrared spectroscopy-based neurofeedback training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham neurofeedback
Number of subjects: 0
Study: 32679568

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) at 60%-90% HR reserve
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Aerobic Continuous Training at 50%-65% HR reserve
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (normal daily physical activity)
Number of subjects: 30
Study: 33409756

Group type: EXPERIMENTAL
Intervention: Standard IVF insemination
Number of subjects: 577

Group type: COMPARATOR
Intervention: ICSI insemination
Number of subjects: 577
Study: 34162777

Group type: EXPERIMENTAL
Intervention: Pharmaceutical consultation targeting outpatients by a pharmacist
Number of subjects: 33

Group type: COMPARATOR
Intervention: Nonintervention (no pharmaceutical consultation)
Number of subjects: 33
Study: 35384630

Group type: EXPERIMENTAL
Intervention: Participatory workplace intervention with individual guidance by an occupational physiotherapist (OPT)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Standard counselling and guidance by an OPT without workplace intervention
Number of subjects: 107
Study: 33941677

Group type: EXPERIMENTAL
Intervention: Active tDCS (anodal and cathodal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study: 32601011

Group type: EXPERIMENTAL
Intervention: Yakson
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Gentle Human Touch (GHT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 34784108

Group type: EXPERIMENTAL
Intervention: Test formulation (0.5 g single oral PZA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation (0.5 g single oral PZA)
Number of subjects: 24
Study: 33164264

Group type: EXPERIMENTAL
Intervention: Pulmonary Daoyin (PD) programme, 2 times a day, 5 days/week for 2 months
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Exercise group (stationary cycle ergometer), 30 min/day, 5 days/week for 2 months
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (maintaining usual activities)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Pulmonary Daoyin (PD) programme
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Pulmonary Daoyin (PD) programme and Exercise group
Number of subjects: 96
Study: 34290666

Group type: EXPERIMENTAL
Intervention: High-concentration oxygen treatment [FiO280 (8 L/min)] for 6 hours
Number of subjects: 600

Group type: COMPARATOR
Intervention: Low-oxygen treatment [FiO230 (2 L/min)] for 6 hours
Number of subjects: 600
Study: 32398304

Group type: EXPERIMENTAL
Intervention: CFTR Phe508del carriers
Number of subjects: 108034

Group type: COMPARATOR
Intervention: Non-carriers
Number of subjects: 108034
Study: 34865278

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: PRP + subcision
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: PRP + combined peeling (GA 70% + TCA 35%)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (contralateral side of each patient)
Number of subjects: 75
Study: 33804738

Group type: EXPERIMENTAL
Intervention: Aerobic Continuous Exercise (ACE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined Exercise (CE)
Number of subjects: 36
Study: 32555939

Group type: EXPERIMENTAL
Intervention: Esmolol (0.5‐mg/kg bolus followed by infusion at 15 µg/kg/min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (30 mL bolus and infusion)
Number of subjects: 40
Study: 33576244

Group type: EXPERIMENTAL
Intervention: Adolescent BPD group (aged 15 to 17 years; n = 64)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Young adult BPD group (aged 18 to 25 years; n = 75)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 139

Group type: COMPARATOR
Intervention: Comparison of adolescents and young adults
Number of subjects: 139
Study: 34321278

Group type: EXPERIMENTAL
Intervention: Trastuzumab and lapatinib
Number of subjects: 455
Study: 35189830

Group type: EXPERIMENTAL
Intervention: VECTRON™ T500 (broflanilide 50% WP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Fludora® Fusion (clothianidin 50% WP + deltamethrin 6.25% WP)
Number of subjects: 16
Study: 34933721

Group type: EXPERIMENTAL
Intervention: Transplanted cartilage tissue and implants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Implants only
Number of subjects: 30
Study: 32516820

Group type: EXPERIMENTAL
Intervention: Video model of the hearing testing procedures
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 34990776

Group type: EXPERIMENTAL
Intervention: Adjuvant Trastuzumab Emtansine (T-DM1)
Number of subjects: 497

Group type: COMPARATOR
Intervention: Paclitaxel plus Trastuzumab (TH)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Whole Breast Radiation Therapy (WBRT) with T-DM1
Number of subjects: 497

Group type: COMPARATOR
Intervention: Whole Breast Radiation Therapy (WBRT) with TH
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: T-DM1
Number of subjects: 497

Group type: COMPARATOR
Intervention: TH
Number of subjects: 497
Study: 32707342

Group type: EXPERIMENTAL
Intervention: Simtuzumab
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 33012517

Group type: EXPERIMENTAL
Intervention: 1.5 ml kg−1 caudal injection of 0.2% ropivacaine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Injection pauses during caudal block
Number of subjects: 15
Study: 33197159

Group type: EXPERIMENTAL
Intervention: Cryoablation
Number of subjects: 303

Group type: COMPARATOR
Intervention: Antiarrhythmic drug therapy
Number of subjects: 303
Study: 32553878

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no PRP)
Number of subjects: 34
Study: 34942228

Group type: EXPERIMENTAL
Intervention: Mindful Mood Balance (MMB) paired with usual depression care (UDC)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual depression care (UDC)
Number of subjects: 109
Study: 32029439

Group type: EXPERIMENTAL
Intervention: Intermediate-dose cytarabine
Number of subjects: 591

Group type: COMPARATOR
Intervention: Conventional-dose cytarabine
Number of subjects: 591

Group type: EXPERIMENTAL
Intervention: Two courses of intermediate-dose cytarabine with daunorubicin or mitoxantrone
Number of subjects: 591
Study: 35654569

Group type: EXPERIMENTAL
Intervention: Flossing
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Mouthrinse
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Combined use of brushing, flossing, and mouthrinse
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Non-habitual users
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Risk perception of developing oral disease
Number of subjects: 213
Study: 32556481

Group type: EXPERIMENTAL
Intervention: 2D-CNN slice-based approach
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: 2D-CNN case-based approach
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: 3D-CNN case-based approach
Number of subjects: 233
Study: 36253765

Group type: EXPERIMENTAL
Intervention: Citrus peel extract (400 mg containing 0.1 mg of AUR and 3 mg of NAR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34022138

Group type: EXPERIMENTAL
Intervention: Nasal High-Flow Oxygen (NHFS) (40% O2, 40 L/min, 37 °C)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional Nasal Cannula (5 L/min)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nasal High-Flow Oxygen (NHFS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional Nasal Cannula
Number of subjects: 18
Study: 32609069

Group type: EXPERIMENTAL
Intervention: Under body forced air heating
Number of subjects: 35

Group type: COMPARATOR
Intervention: Over body forced air heating
Number of subjects: 35
Study: 36404171

Group type: EXPERIMENTAL
Intervention: MVC-COV1901
Number of subjects: 1030

Group type: COMPARATOR
Intervention: AZD1222
Number of subjects: 1030
Study: 33884929

Group type: EXPERIMENTAL
Intervention: Weekly pain ratings
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Daily pain ratings
Number of subjects: 119

Group type: COMPARATOR
Intervention: Weekly ratings compared to daily ratings
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Weekly ratings
Number of subjects: 119
Study: 33465293

Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 0
Study: 32059710

Group type: EXPERIMENTAL
Intervention: Baseline salivary methylation of Cg1307483 (NRF1)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Baseline child BMI-Z
Number of subjects: 92
Study: 36079806

Group type: EXPERIMENTAL
Intervention: Clostridium butyricum
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 33715657

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lurasidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antidepressant monotherapy
Number of subjects: 0
Study: 35102419

Group type: EXPERIMENTAL
Intervention: HAW-R (High-Amylose Wheat Refined)
Number of subjects: 80

Group type: COMPARATOR
Intervention: LAW-R (Low-Amylose Wheat Refined)
Number of subjects: 80
Study: 34906099

Group type: EXPERIMENTAL
Intervention: Green health scenario (21121)
Number of subjects: 2854

Group type: COMPARATOR
Intervention: Yellow health scenario (22222)
Number of subjects: 2854
Study: 36160174

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine for scalp nerve block (SNB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 50
Study: 36401369

Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sitting position
Number of subjects: 20
Study: 35613418

Group type: EXPERIMENTAL
Intervention: Topical ganciclovir 0.15% ophthalmic gel (1 drop 3 times daily, n = 6 cats)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Oral famciclovir (90 mg/kg twice daily, n = 6)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Topical artificial tear gel (1 drop 3 times daily, n = 4)
Number of subjects: 16
Study: 33814247

Group type: EXPERIMENTAL
Intervention: High target group (mean arterial pressure 85 mmHg)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Normal target group (mean arterial pressure 65 mmHg)
Number of subjects: 78
Study: 36429924

Group type: EXPERIMENTAL
Intervention: Real tDCS with MI and upper-limb functional training
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham tDCS with MI and upper-limb functional training
Number of subjects: 64
Study: 32768690

Group type: EXPERIMENTAL
Intervention: 3-item self-reported measure of adherence to medication
Number of subjects: 459

Group type: COMPARATOR
Intervention: Claims-based adherence measures
Number of subjects: 459
Study: 34124840

Group type: EXPERIMENTAL
Intervention: Coconut oil
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sesame oil
Number of subjects: 24
Study: 35670139

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation
Number of subjects: 3318
Study: 34010546

Group type: EXPERIMENTAL
Intervention: Concurrent Training (CT) with 15% velocity loss (VL15)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Concurrent Training (CT) with 45% velocity loss (VL45)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Endurance Training (ET)
Number of subjects: 33
Study: 36176445

Group type: EXPERIMENTAL
Intervention: Jianpi Huatan granule (JHG) for 3 months
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 350
Study: 36331315

Group type: EXPERIMENTAL
Intervention: Inclisiran 284 mg
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study: 33229200

Group type: EXPERIMENTAL
Intervention: Spaghetti (S)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rice (R)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rice (R) with Pesto (P)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spaghetti (S) with Pesto (P)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rice (R) with Extra Virgin Olive Oil (EVOO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spaghetti (S) with Extra Virgin Olive Oil (EVOO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rice (R) and Spaghetti (S) consumed plain
Number of subjects: 0
Study: 35945594

Group type: EXPERIMENTAL
Intervention: Rosa foetida extract capsules
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 0

Group type: COMPARATOR
Intervention: No medication
Number of subjects: 0
Study: 34770116

Group type: EXPERIMENTAL
Intervention: Sit-stand desk intervention
Number of subjects: 74
Study: 32585581

Group type: EXPERIMENTAL
Intervention: Z5 (5 mg/kg/day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Z10 (10 mg/kg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 35128915

Group type: EXPERIMENTAL
Intervention: Big Data Telematics intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33612438

Group type: EXPERIMENTAL
Intervention: Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA24-2016)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Diet History Questionnaire II (DHQ-II)
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Combination of ASA24-2016 recalls and DHQ-II
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: First ASA24-2016 recall
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: DHQ-II
Number of subjects: 331
Study: 32843320

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 130
Study: 35171742

Group type: EXPERIMENTAL
Intervention: Enhanced training group using Clip-Tone training aid linked to smartphone app
Number of subjects: 221

Group type: COMPARATOR
Intervention: Verbal training group
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 221
Study: 34258913

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg, every night for 4 weeks)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Combined group (evolocumab, 140 mg, once every 2 weeks on top of atorvastatin 20 mg per day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (Atorvastatin only)
Number of subjects: 64
Study: 34915980

Group type: EXPERIMENTAL
Intervention: 5%-10% weight loss group (5%-10%WLG)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: ≥ 10% weight loss group (≥ 10%WLG)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: < 5% weight loss group (< 5%WLG)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Weight-stable/gain group (WS/GG)
Number of subjects: 180
Study: 32321768

Group type: EXPERIMENTAL
Intervention: Second-line chemotherapy
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Third-line chemotherapy
Number of subjects: 233
Study: 36239695

Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) (ad libitum eating within 12 hours)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard dietary advice (SDA) (food pyramid brochure)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard dietary advice (SDA)
Number of subjects: 42
Study: 34284351

Group type: EXPERIMENTAL
Intervention: Caffeine 4 mg/kg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Caffeine 2 mg/kg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Caffeine 0 mg/kg (placebo)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Caffeine (all doses)
Number of subjects: 102
Study: 32529353

Group type: EXPERIMENTAL
Intervention: Triangular port placement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midline port placement
Number of subjects: 0
Study: 36132545

Group type: EXPERIMENTAL
Intervention: Nursing model (observation group)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Conventional model (control group)
Number of subjects: 142
Study: 34049837

Group type: EXPERIMENTAL
Intervention: Self-management intervention (exercise + education) including bi-weekly supervised exercise sessions and 30 min of education for 16 weeks (8 weeks supervised + 8 weeks self-guided with phone coaching)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 32039875

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over the left angular gyrus (fifteen sessions of 1800 magnetic pulses)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham stimulation (fifteen sessions)
Number of subjects: 28
Study: 35905117

Group type: EXPERIMENTAL
Intervention: Psycho-education intervention delivered in 6 sessions to 40 participants and their family members
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 80
Study: 34604969

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced ultrasound (CEUS) with 4.8 mL of SonoVue
Number of subjects: 232

Group type: COMPARATOR
Intervention: Conventional transthoracic ultrasound (TUS)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: CEUS for lesions sized between 1-2 cm
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: CEUS for lesions sized between 2-5 cm
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: CEUS for necrotic lesions
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Both groups (CEUS and TUS)
Number of subjects: 232
Study: 34232137

Group type: EXPERIMENTAL
Intervention: Randomized controlled trial of CDI treatment in children
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation in children
Number of subjects: 0
Study: 35970020

Group type: EXPERIMENTAL
Intervention: Corbevax (two‐dose schedule with 28 days of interval between doses)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Corbevax with 750 µg of CpG1018
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Corbevax
Number of subjects: 460
Study: 32734461

Group type: EXPERIMENTAL
Intervention: ASP3652 300 mg twice daily
Number of subjects: 287

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study: 35629175

Group type: EXPERIMENTAL
Intervention: MULTIPAP intervention based on the Ariadne principles (FP training and FP patient interviews)
Number of subjects: 593

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 593
Study: 33455117

Group type: EXPERIMENTAL
Intervention: Osteosarcoma cell lines MG63 and HOS with methylation inhibitor
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: MG63 cell line
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (non-osteosarcoma)
Number of subjects: 51
Study: 35485658

Group type: EXPERIMENTAL
Intervention: Therapeutic exercises with an instructor and low‐intensity laser exposure
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Therapeutic exercises with an instructor, low‐intensity laser therapy, and PLFEF
Number of subjects: 90

Group type: COMPARATOR
Intervention: Therapeutic exercises with an instructor
Number of subjects: 90
Study: 32768874

Group type: EXPERIMENTAL
Intervention: intermittent MI and tCBT (iMI + tCBT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: tCBT and psychoeducation
Number of subjects: 36